Efficacy and safety of Chunghyul-dan (Qingwie-dan) in patients with hypercholesterolemia

American Journal of Chinese Medicine

Volumn 33, Issue 2, 2005, Pages 241-248

  Cho, Ki Ho ^a   Kang, Heung Sun ^b   Jung, Woo Sang ^a   Park, Seong Uk ^a   Moon, Sang Kwan ^a  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

Atorvastatin; Chunghyul dan; Coptidis Rhizoma; Hypercholesterolemia; Phellodendri Cortex; Scutellariae Radix

Indexed keywords

ATORVASTATIN; BAICALIN; BERBERINE; CHUNGHYUL DAN; COPTIS RHIZOME; GARDENIA EXTRACT; GENIPOSIDE; HERBACEOUS AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LIPID; PLACEBO; QINGWIE DAN; RHUBARB EXTRACT; SCUTELLARIAE RADIX; SENNOSIDE A; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENZYME INHIBITION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIVER TOXICITY; MALE; NEPHROTOXICITY; OPEN STUDY;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; DRUGS, CHINESE HERBAL; FEMALE; HEPTANOIC ACIDS; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PLACEBOS; PYRROLES; TREATMENT OUTCOME;

EID: 18744412136     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X05002898     Document Type: Article

References (27)

1. Abe, I., T. Seki, H. Noguchi and Y. Kashiwada. Galloyl esters from rhubarb are potent inhibitors of squalene epoxidase, a key enzyme in cholesterol biosynthesis. Planta Med. 66(8): 753-756, 2000.
2. Alexandridis, G., G.A. Pappas and M.S. Elisaf. Rhabdomyolysis due to combination therapy with cerivastatin and gemfibrozil. Am. J. Med. 109(3): 261-262, 2000.
3. Ansell, B.J. Cholesterol, stroke risk, and stroke prevention. Curr. Atheroscler. Rep. 2(2): 92-96, 2000.
4. Bae, J.H., J.E. Jun, W.H. Park, K.B. Kim, K.S. Kim, J.W. Lee, W.R. Lee, J.E. Park, Y.S. Choi, Y.J. Kwon, J.C. Kang, J.J. Kim, Y. Moon, S.P. Hong, T.H. Kim, Y.J. Kim, B.S. Shim, S.J. Park, J.W. Jung, K.J. Rhee, K.B. Choi, C.Y. Rim and B.H. Lee. Multicenter clinical trial of Atorvastatin in patients with hypercholesterolemia. Korean Circ. J. 31(4): 434-441, 2001.
5. Black, D., M. Davidson, M. Koren, R. Bakker-Arkema, P. Tresh, R. McLain, D. Smith and D. Hunninghake. Cost effectiveness of treatment to National Cholesterol Education Panel (NCEP) targets with HMG-CoA reductase inhibitors. Pharmacoeconomics 12(2): 275-285, 1997.
6. Chun, K.J., N.S. Chung, J.W. Ha, S.K. Ahn, S.J. Rim, Y.S. Jang, W.H. Sim, S.Y. Cho, S.S. Kim, S.H. Lee and M.J. Shin Efficacy and safety of Atorvastatin in patients with elevated LDL-cholesterolemia. Korean Circ. J. 29(12): 1309-1316, 1999.
7. Hayakawa, J., N. Noda, S. Yamada, E. Mikami and K. Uno. Studies on physical chemical quality evaluation of crude drugs preparations. III. Analysis of gardenia fruits and its preparations. Yakugadu Zasshi 105(10): 996-1000, 1985.
8. Hendriks, F., J.P. Kooman and F.M. van der Sande. Massive rhabdomyolysis and life threatening hyperkalaemia in a patient with the combination of cerivastatin and gemfibrozil. Nephrol. Dial. Transplant. 16(12): 2418-2419, 2001.
9. Iijima, O.T., H. Takeda and T. Matsumiya. Effects of San'o-shashin-to on the antioxidative mechanism in spontaneous familial hypercholesterolaemic rabbits. Pharmacol. Res. 41(2): 137-141, 2000.
10. Insull, W., S. Kafonek, D. Goldner and F. Zieve. Comparison of efficacy and safety of Atorvastatin (10 mg) with Simvastatin (10 mg) at six weeks. Am. J. Cardiol. 87: 554-559, 2001.
11. Kim, C.J., Y.D. Kim, D.J. Oh, B.H. Oh, M.M. Lee, Y.B. Park, Y.S. Choi, J.D. Seo and Y.W. Lee. Effect of Bezafibrate in patients with hyperlipidemia. Korean Circ. J. 19(3): 497-502, 1989.
12. Kim, J.S., I.H. Chai, S.W. Park, S.K. Hong, H.S. Kim, C.H. Kim, D.W. Sohn, B.H. Oh, M.M. Lee, Y.B. Park, Y.S. Choi, J.D. Seo and Y.W. Lee. Clinical efficacy of Lovastatin in patients with hypercholesterolemia. Korean Circ. J. 22(1): 121-129, 1992a.
13. Kim, J.S., K.H. Han, S.W. Park, J.K. Bang, S.K. Hong, D.W. Sohn, B.H. Oh, M.M. Lee, Y.B. Park, Y.S. Choi, J.D. Seo and Y.W. Lee. Clinical efficacy of Pravastatin in patients with hypercholesterolemia. Korean Circ. J. 22(1): 113-120, 1992b.
14. Kim, Y.S., E.A. Jung, J.C. Jang, H.K. Yang, N.J. Kim, K.H. Cho, H.S. Bae, K.S. Lee and D.H. Kim. Anti-hyperlipidemic effect of Daehwang-hwangryeonhaedok-tang on hyperlipidemia. Korean J. Pharmacog. 32(2): 145-152, 2001.
15. Kim, Y.S., E.A. Jung, J.E. Shin, J.C. Chung, H.K. Yang, N.J. Kim, K.H. Cho, H.S. Bae, S.K. Moon and D.H. Kim. Daio-Orengedokuto inhibits HMG-CoA reductase and pancreatic lipase. Biol. Pharm. Bull. 25(11): 1442-1445, 2002.
16. Kimura, Y., H. Okuda, Z. Taira, N. Shoji, T. Takemoto and S. Arichi. Studies on Scutellariae radix. IX. New component inhibiting lipid peroxidation in rat liver. Planta Med. 50(4): 290-295, 1984.
17. Koh, J.H., J.H. Shin, H.S. Kim, S.J. Tahk, B.I. Choi, D.S. Kim, H.M. Kwon and H.S. Kim. Efficacy and safety of Atorvastatin in patients with hypercholesterolemia. Korean Circ. J. 29(9): 928-936, 1999.
18. Lee, Y.J. The effects of fraction obtained from Rhei Rhizoma on the blood lipids in hypercholesterol rats. J. Korean Herbol. 15(2): 87-93, 2000.
19. Martin, M., W.S. Brownerr, D. Wentworth, S.B. Hulley and L.H. Kukker. Serum cholesterol, blood pressure and mortality: Implications from a cohort of 361,662 men. Lancet 2(8513): 933-936, 1986.
20. Martin-Jadraque, R., F. Tato, J.M. Mostaza, G.L. Vega and S.M. Grundy. Effectiveness of low-dose crystalline nicotinic acid in men with low high-density lipoprotein cholesterol levels. Arch. Intern. Med. 156(10): 1081-1088, 1996.
21. Roh, H.S., W.K. Koh, W.J. Kim, K.K. Park, Y.H. Cho and H.S. Park. Anti-hyperlipidemic activity of Scutellaris baicalensis Georg., Coptidis japonica Makino and Rhei koreanum Nakai on experimental hyperlipidemia in rats. J. Korean Pharma. Sci. 26(3): 215-219, 1996.
22. Scheen, A.J. Fatal rhabdomyolysis caused by cerivastatin. Rev. Med. Liege. 56(8): 592-594, 2001.
23. Shin, H.H. Hyperlipidemia. Korean J. Fam. Med. 19(5): S292-S303, 1998.
24. Son, Y.J., Y.S. Kim and Y.J. Kim. The effects of Rhei palmate radix and Rhei undulati radix on the blood lipids and enzymes of hypercholesterolic rats. J. Korean Herbol. 14(1): 61-68, 1999.
25. Stamler, J., D. Wentworth and J.D. Neaton from the MRFIT Reasearch Group. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenes of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 256: 2823-2828, 1986.
26. Yee, H.S. and N.T. Fong. Atorvastatin in the treatment of primary hypercholesterolemia and mixed dyslipidemias. DICP 32(10): 1030-1043, 1998.
27. Yoon, B.B. Management and treatment on hyperlipidemia. Korean J. Fam. Med. 22(5): S75-S79, 2001.